Cosmo Pharmaceuticals
C43.F
#5349
Rank
HK$8.64 B
Marketcap
HK$537.22
Share price
-1.50%
Change (1 day)
55.70%
Change (1 year)

Operating Margin for Cosmo Pharmaceuticals (C43.F)

Operating Margin at the end of 2022: 23.97%

According to Cosmo Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 23.97%. At the end of 2022 the company had an Operating Margin of 23.97%.

Operating Margin history for Cosmo Pharmaceuticals from 2004 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202223.97%-35.01%
202136.89%-424.36%
2020-11.37%-66.64%
2019-34.09%28.12%
2018-26.61%-44.83%
2017-48.23%-218.71%
201640.63%-90.32%
2015419.57%206.8%
2014136.76%7.56%
2013127.15%180.93%
201245.26%66.79%
201127.14%95.05%
201013.91%-30.18%
200919.93%-41.37%
200833.98%4764.23%
20070.70%-78.99%
20063.32%-60.67%
20058.45%-176.44%
2004-11.06%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.